Print Page      Close Window     

SEC Filings

20-F
TRIVAGO N.V. filed this Form 20-F on 03/06/2018
Entire Document
 



Cash Flows Used in Investing Activities
For the year ended December 31, 2017, cash used in investing activities increased by €9.3 million to €(18.3) million, primarily due to increased capital expenditures including internal-use software and website development and the acquisition of tripl GmbH for €0.7 million.
For the year ended December 31, 2016, cash used in investing activities increased by €2.5 million to €(9.0) million, primarily due to increased capital expenditures including internal-use software and website development and the acquisition of the base7 minority interest for €0.9 million.
For the year ended December 31, 2015, cash used in investing activities increased by €1.9 million, from €(4.6) million for the year ended December 31, 2014 to €(6.5) million for the year ended December 31, 2015, primarily due to acquisitions and increased capital expenditures including internal-use software and website development. 
Cash Flows Provided by/(Used in) Financing Activities
For the year ended December 31, 2017, cash used in financing activities increased by €194.9 million to €7.2 million of cash used. This was driven primarily by one-time IPO net proceeds in 2016 of €207.8 million, partially offset by a €20.0 million net payment on the credit facility during the year ended December 31, 2016. The negative cash flow from financing activities in 2017 was primarily due to payments of IPO costs of €4.0 million and tax payments for shares withheld of €3.1 million.
For the year ended December 31, 2016, cash provided by financing activities increased by €168.7 million to €187.6 million. This was driven primarily by IPO net proceeds of €207.8 million, and a €20.0 million draw down on the credit facility during the year ended December 31, 2015 compared to a €20.0 million net payment on the credit facility during the year ended December 31, 2016.
For the year ended December 31, 2015, cash provided by financing activities increased by €18.0 million million, from €1.0 million for the year ended December 31, 2014 to €19.0 million for the year ended December 31, 2015 and primarily included €20.0 million in proceeds from a draw-down of our credit facility, partially offset by the repayment of a €1.0 million loan from Expedia.
C.
Research and development expenses, patents and licenses, etc.
See “Item 4 B. Information on the company—Business overview.”
D.
Trend information
See “Item 5 Operating and financial review and prospects—Operating results.”
E.
Off-balance sheet arrangements
Other than the items described below under “—Tabular disclosure of contractual obligations,” as of December 31, 2017, we do not have any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

81